P21‑activated kinase 1 mediates angiotensin II‑induced differentiation of human atrial fibroblasts via the JNK/c‑Jun pathway

Zhou,Yafei; Xie,Ying; Li,Tao; Zhang,Peng; Chen,Tangting; Fan,Zhongcai; Tan,Xiaoqiu

doi:10.3892/mmr.2021.11846

P21‑activated kinase 1 mediates angiotensin II‑induced differentiation of human atrial fibroblasts via the JNK/c‑Jun pathway

Authors:
- Yafei Zhou
- Ying Xie
- Tao Li
- Peng Zhang
- Tangting Chen
- Zhongcai Fan
- Xiaoqiu Tan
View Affiliations

Affiliations: Key Laboratory of Medical Electrophysiology of the Ministry of Education, and Medical Electrophysiological Key Laboratory of Sichuan Province, Institute of Cardiovascular Research, Southwest Medical University, Luzhou, Sichuan 646000, P.R. China, Key Laboratory of Medical Electrophysiology of the Ministry of Education, and Medical Electrophysiological Key Laboratory of Sichuan Province, Institute of Cardiovascular Research, Southwest Medical University, P.R. China, Department of Cardiovascular Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, P.R. China
Published online on: January 18, 2021 https://doi.org/10.3892/mmr.2021.11846
Article Number: 207
Copyright: © Zhou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Cardiac fibrosis is a common pathophysiological condition involved in numerous types of cardiovascular disease. The renin‑angiotensin system, particularly angiotensin II (AngII), serves an important role in cardiac fibrosis and remodeling. Furthermore, p21‑activated kinase 1 (PAK1) is a highly conserved serine/threonine protein kinase, which is abundantly expressed in all regions of the heart. However, the role of PAK1 in AngII‑mediated activation of cardiac fibroblasts remains unknown. Therefore, the present study aimed to investigate the role of PAK1 in cardiac fibroblasts and its underlying mechanisms. Human cardiac fibroblasts (HCFs) were cultured and treated with PAK1 inhibitor IPA‑3 or transduced with PAK1 short hairpin (sh)RNA by lentiviral particles to silence PAK1 expression levels. Subsequently, the cell proliferation and migration abilities of the HCFs were determined. Western blot analysis was used to detect the phosphorylation status of Janus kinase (JNK) and c‑Jun. A Cell Counting Kit‑8 assay showed that PAK1 inhibition following treatment of HCFs with 5 µM IPA‑3 or PAK1‑shRNA, significantly attenuated AngII‑induced proliferation of fibroblasts. In addition, wound healing and Transwell migration assays demonstrated that inhibition of PAK1 significantly inhibited AngII‑induced cell migration. Finally, decreased PAK1 expression levels downregulated AngII‑mediated upregulation of α‑smooth muscle actin (α‑SMA), collagen I, phosphorylated (p)‑JNK and p‑c‑Jun, a downstream molecule of JNK signaling. These findings indicate that PAK1 contributes to AngII‑induced proliferation, migration and transdifferentiation of HCFs via the JNK/c‑Jun pathway.

View Figures

View References

1	Frangogiannis NG: Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities. Mol Aspects Med. 65:70–99. 2019. View Article : Google Scholar : PubMed/NCBI
2	Prabhu SD and Frangogiannis NG: The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis. Circ Res. 119:91–112. 2016. View Article : Google Scholar : PubMed/NCBI
3	Ma ZG, Yuan YP, Wu HM, Zhang X and Tang QZ: Cardiac fibrosis: New insights into the pathogenesis. Int J Biol Sci. 14:1645–1657. 2018. View Article : Google Scholar : PubMed/NCBI
4	Humeres C and Frangogiannis NG: Fibroblasts in the Infarcted, Remodeling, and Failing Heart. JACC Basic Transl Sci. 4:449–467. 2019. View Article : Google Scholar : PubMed/NCBI
5	Ji Y, Qiu M, Shen Y, Gao L, Wang Y, Sun W, Li X, Lu Y and Kong X: MicroRNA-327 regulates cardiac hypertrophy and fibrosis induced by pressure overload. Int J Mol Med. 41:1909–1916. 2018.PubMed/NCBI
6	Kong P, Christia P and Frangogiannis NG: The pathogenesis of cardiac fibrosis. Cell Mol Life Sci. 71:549–574. 2014. View Article : Google Scholar : PubMed/NCBI
7	Weber KT: Fibrosis in hypertensive heart disease: Focus on cardiac fibroblasts. J Hypertens. 22:47–50. 2004. View Article : Google Scholar : PubMed/NCBI
8	Frangogiannis NG: Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities. Mol Aspects Med. 65:70–99. 2019. View Article : Google Scholar : PubMed/NCBI
9	Ma H, Kong J, Wang YL, Li JL, Hei NH, Cao XR, Yang JJ, Yan WJ, Liang WJ, Dai HY and Dong B: Angiotensin-converting enzyme 2 overexpression protects against doxorubicin-induced cardiomyopathy by multiple mechanisms in rats. Oncotarget. 8:24548–24563. 2017. View Article : Google Scholar : PubMed/NCBI
10	Chen T, Li M, Fan X, Cheng J and Wang L: Sodium Tanshinone IIA Sulfonate Prevents Angiotensin II–Induced Differentiation of Human Atrial Fibroblasts into Myofibroblasts. Oxid Med Cell Longev. 2018:67125852018. View Article : Google Scholar : PubMed/NCBI
11	Dong X, Yu S, Wang Y, Yang M, Xiong J, Hei N, Dong B, Su Q and Chen J: (Pro)renin receptor-mediated myocardial injury, apoptosis, and inflammatory response in rats with diabetic cardiomyopathy. J Biol Chem. 294:8218–8226. 2019. View Article : Google Scholar : PubMed/NCBI
12	Li R, Xiao J, Qing X, Xing J, Xia Y, Qi J, Liu X, Zhang S, Sheng X, Zhang X, et al: Sp1 Mediates a Therapeutic Role of MiR-7a/b in Angiotensin II–Induced Cardiac Fibrosis via Mechanism Involving the TGF-β and MAPKs Pathways in Cardiac Fibroblasts. PLoS One. 10:e01255132015. View Article : Google Scholar : PubMed/NCBI
13	Działo E, Tkacz K and Błyszczuk P: Crosstalk between the TGF-β and WNT signalling pathways during cardiac fibrogenesis. Acta Biochim Pol. 65:341–349. 2018. View Article : Google Scholar : PubMed/NCBI
14	Gu J, Liu X, Wang QX, Tan HW, Guo M, Jiang WF and Zhou L: Angiotensin II increases CTGF expression via MAPKs/TGF-β1/TRAF6 pathway in atrial fibroblasts. Exp Cell Res. 318:2105–2115. 2012. View Article : Google Scholar : PubMed/NCBI
15	Trial J and Cieslik KA: Changes in cardiac resident fibroblast physiology and phenotype in aging. Am J Physiol Heart Circ Physiol. 315:H745–H755. 2018. View Article : Google Scholar : PubMed/NCBI
16	Rane CK and Minden A: P21 activated kinase signaling in cancer. Semin Cancer Biol. 54:40–49. 2019. View Article : Google Scholar : PubMed/NCBI
17	Sun X, Su VL and Calderwood DA: The subcellular localization of type I p21-activated kinases is controlled by the disordered variable region and polybasic sequences. J Biol Chem. 294:14319–14332. 2019. View Article : Google Scholar : PubMed/NCBI
18	Rudolph J, Crawford JJ, Hoeflich KP and Wang W: Inhibitors of p21-activated kinases (PAKs). J Med Chem. 58:111–29. 2015. View Article : Google Scholar : PubMed/NCBI
19	Wang Y, Wang S, Lei M, Boyett M, Tsui H, Liu W and Wang X: The p21-activated kinase 1 (Pak1) signalling pathway in cardiac disease: From mechanistic study to therapeutic exploration. Br J Pharmacol. 175:1362–1374. 2018. View Article : Google Scholar : PubMed/NCBI
20	Al-Azayzih A, Gao F and Somanath PR: P21 activated kinase-1 mediates transforming growth factor β1-induced prostate cancer cell epithelial to mesenchymal transition. Biochim Biophys Acta. 1853:1229–1239. 2015. View Article : Google Scholar : PubMed/NCBI
21	Chen QY, Xu LQ, Jiao DM, Yao QH, Wang YY, Hu HZ, Wu YQ, Song J, Yan J and Wu LJ: Silencing of Rac1 modifies lung cancer cell migration, invasion and actin cytoskeleton rearrangements and enhances chemosensitivity to antitumor drugs. Int J Mol Med. 28:769–776. 2011.PubMed/NCBI
22	Yang Y, Du J, Hu Z, Liu J, Tian Y, Zhu Y, Wang L and Gu L: Activation of Rac1-PI3K/Akt is required for epidermal growth factor-induced PAK1 activation and cell migration in MDA-MB-231 breast cancer cells. J Biomed Res. 25:237–245. 2011. View Article : Google Scholar : PubMed/NCBI
23	Zhang C, Lee HJ, Shrivastava A, Wang R, McQuiston TJ, Challberg SS, Pollok BA and Wang T: Long-Term In Vitro Expansion of Epithelial Stem Cells Enabled by Pharmacological Inhibition of PAK1-ROCK-Myosin II and TGF-β Signaling. Cell Rep. 25:598–610.e5. 2018. View Article : Google Scholar : PubMed/NCBI
24	Liu W, Zi M, Naumann R, Ulm S, Jin J, Taglieri DM, Prehar S, Gui J, Tsui H, Xiao RP, et al: Pak1 as a novel therapeutic target for antihypertrophic treatment in the heart. Circulation. 124:2702–2715. 2011. View Article : Google Scholar : PubMed/NCBI
25	Buttke TM, McCubrey JA and Owen TC: Use of an aqueous soluble tetrazolium/formazan assay to measure viability and proliferation of lymphokine-dependent cell lines. J Immunol Methods. 157:233–240. 1993. View Article : Google Scholar : PubMed/NCBI
26	Mazzei M, Vascellari M, Zanardello C, Melchiotti E, Vannini S, Forzan M, Marchetti V, Albanese F and Abramo F: Quantitative real time polymerase chain reaction (qRT-PCR) and RNAscope in situ hybridization (RNA-ISH) as effective tools to diagnose feline herpesvirus-1-associated dermatitis. Vet Dermatol. 30:491–e147. 2019. View Article : Google Scholar : PubMed/NCBI
27	Talman V and Ruskoaho H: Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration. Cell Tissue Res. 365:563–581. 2016. View Article : Google Scholar : PubMed/NCBI
28	Holtz J: Pathophysiology of heart failure and the renin-angiotensin-system. Basic Res Cardiol. 88 (Suppl 1):183–201. 1993.PubMed/NCBI
29	Petrov VV, Fagard RH and Lijnen PJ: Stimulation of collagen production by transforming growth factor-beta1 during differentiation of cardiac fibroblasts to myofibroblasts. Hypertension. 39:258–263. 2002. View Article : Google Scholar : PubMed/NCBI
30	Harada M, Luo X, Qi XY, Tadevosyan A, Maguy A, Ordog B, Ledoux J, Kato T, Naud P, Voigt N, et al: Transient receptor potential canonical-3 channel-dependent fibroblast regulation in atrial fibrillation. Circulation. 126:2051–2064. 2012. View Article : Google Scholar : PubMed/NCBI
31	Alex L and Frangogiannis NG: The Cellular Origin of Activated Fibroblasts in the Infarcted and Remodeling Myocardium. Circ Res. 122:540–542. 2018. View Article : Google Scholar : PubMed/NCBI
32	Hirsch AT, Pinto YM, Schunkert H and Dzau VJ: Potential role of the tissue renin-angiotensin system in the pathophysiology of congestive heart failure. Am J Cardiol. 66:D22–D332. 1990. View Article : Google Scholar
33	Sabapathy K, Hochedlinger K, Nam SY, Bauer A, Karin M and Wagner EF: Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation. Mol Cell. 15:713–725. 2004. View Article : Google Scholar : PubMed/NCBI
34	Harms FL, Kloth K, Bley A, Denecke J, Santer R, Lessel D, Hempel M and Kutsche K: Activating Mutations in PAK1, Encoding p21-Activated Kinase 1, Cause a Neurodevelopmental Disorder. Am J Hum Genet. 103:579–591. 2018. View Article : Google Scholar : PubMed/NCBI